Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-12-23

Clinical Trial Update: Investigation of Efficacy and Tolerability of a Lactic Acid Containing Vaginal Suppository in Post-menopausal Women With VVA [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating lactic acid-containing vaginal suppository for efficacy and tolerability in post-menopausal vulvovaginal atrophy has completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • lactic acid-containing vaginal suppository

Snippet

Sponsor: Dr. August Wolff GmbH & Co. KG Arzneimittel | Conditions: Vulvovaginal Atrophy | Phase 2 | Status: COMPLETED